By a News Reporter-Staff News Editor at Politics& Government Week A patent application by the inventors Chatterjee, Samir; Lee, Edward Kuang-Yu; Alluhaidan, Ala; Alnosayan, Nagla Sulaiman, filed on June 9, 2015, was made available online on December 17, 2015, according to news reporting originating from Washington, D.C., by VerticalNews correspon
Others ask how their name popped up on the Blue Cross call list. Blue Cross, the state's largest health insurer, is engaging in an experiment that may one day become standard practice in private health insurance, as the industry contends with rising costs. Using a computer algorithm to identify customers, Blue Cross is deploying teams of nurses and
Dec. 31 At the eleventh hour, BlueCross BlueShield of Arizona and Carondelet Health Network have signed a four-year contract, putting to rest fears that customers of the state's largest insurer could lose in-network access to Carondelet doctors and facilities. The agreement includes all Carondelet hospitals, employed physicians, ambulatory surger
By a News Reporter-Staff News Editor at Politics& Government Week Clovis Oncology, Inc. announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for Clovis' New Drug Application for rociletinib by the standard extension period of three months with the new goal date of June 28, 2016. Clovis Oncology
Data on Neuroendocrine Cancer Reported by Researchers at S. Orsola-Malpighi University Hospital. According to news reporting from Bologna, Italy, by VerticalNews journalists, research stated, "This study was performed to investigate the role of Ga-68-DOTANOC SUVmax as a potential prognostic factor in patients with pancreatic neuroendocrine tumor.
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in Argentina. Economic Outlook:- In spite of the forecasted acceleration in the global economy, for Argentina, the economic growth is expected to slow down in 2015 and make a slight recuperation to growth in 2016.- The
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in UAE. To add context to the surgical procedure volumes, the report provides written and numerical analysis on the current trends, size, changes and dynamics of the local markets. -Abu Dhabi is especially dependent on
Release date- 28122015- Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in Chi
Dec. 31 Israeli placenta-based cell therapy developer Pluristem Therapeutics Ltd. has been awarded orphan drug status by the US Food and Drug Administration for its PLX-PAD cells treatment for severe preeclampsia. We are encouraged by the US FDA designation that demonstrates Pluristem's commitment to the program and the potential promise it holds
Bangor Hydro-Electric Co., et al., 81818 Federal Reserve System NOTICES Changes in Bank Control: Acquisitions of Shares of a Bank or Bank Holding Company, 81818-81819 Fiscal Service NOTICES Prompt Payment Interest Rate; Contract Disputes Act, 81880 Food and Drug Administration NOTICES Guidance: Emerging Postmarket Medical Device Signals, 81829-8183
Global Blood Therapeutics, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet needs, announced today that the U.S. Food and Drug Administration has granted orphan drug designation for GBT440 for the treatment of patients with sickle cell disease.
The legislation repeals key parts of Obamacare, including the individual and employer mandates, the so-called " Cadillac tax" and the medical device tax, and also halts federal funding for Planned Parenthood. The House passed similar legislation in October, but changes to the language of the Senate version of the bill require another vote in the Ho
Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in China, and the acquisition
Haroon Qasim Managing Director of PharmEvo Pharmaceuticals. Shabbar Zaidi, Chartered Accountant and Senior Partner in A.F. Ferguson and Company was the other invited guest speaker on the occasion. We have some of the best hospitals in Karachi like Aga Khan University Hospital, Indus Hospital where their employees are fully involved in the Mission o
The law calls for an ACO to agree to manage the health care needs of at least 5,000 Medicare beneficiaries for at least three years. Georgia Physicians for Accountable Care was formed in mid-2013, and when doctors in the Macon area were first approached, "there was an overwhelming response," Barry said. " While the ACO was only required to get 5,00
Vivian Lee is the CEO of University of Utah Health Care, and her accomplishments in Utah should serve as a model for Vermont. The "sticker price" for medical procedures in Utah, like here in Vermont, bore little to no relationship to the actual costs incurred by the hospital to perform them. Rolling up their sleeves in what she described as "the Ut
Public Notification of Emerging Postmarket Medical Device Signals; Draft Guidance for Industry and Food and Drug Administration Staff; Availability. SUMMARY: The Food and Drug Administration is announcing the availability of the draft guidance entitled "Public Notification of Emerging Postmarket Medical Device Signals." "Historically, FDA has...
Tenders are invited for Rfa Fibre For Bipolar Intraluminal Application For Varicose Veins Detail Specification: Us Fda/ European Ce Approved Quality. Instructions/Remarks: All The Firms Participating In E-Tender Enquiry To Upload The Details Of The Offered Item In The Form Of Scanned Copy Of The Photo Of The Offered Item Showing All Relevant Detail
By a News Reporter-Staff News Editor at Women's Health Weekly Roche announced that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian assay for use on Roche's full portfolio of laboratory analyzers. Alan Wright, Chief Medical Officer, Roche Diagnostics Corporation. The assay is
RowdMap, Inc. CSO Joins Former Principal Deputy Administrator of CMS and CMO of Optum Labs to Translate Value of Public Data to Health Plans, Risk-Bearing Providers. -Joshua Rosenthal, PhD, Chief Scientific Officer at RowdMap, Inc., joins Jonathan Blum, Former Principal Deputy Administrator of the Centers for Medicare and Medicaid and Paul Wallace,
Joshua Rosenthal, PhD, Chief Scientific Officer at RowdMap, Inc., joins Cora Han, Senior Attorney, Division of Privacy and Identity Protection, Federal Trade Commission; Christina Heide, Acting Deputy Director for Health Information Privacy, Office for Civil Rights, U.S. Department of Health& Human Services; and Kim Gray, Chief Privacy Officer, IMS
Teligent, Inc., a New Jersey- based specialty generic pharmaceutical company, today announced it has submitted its fourteenth and fifteenth abbreviated new drug applications to the U.S. Food and Drug Administration of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to thirty-three. We believe our current p
Torrent Pharmaceutical Ltd has obtained the approval of the US Food and Drug Administration to launch a generic arthritis drug. The company will launch Celacoxib capsules in 50 mg, 100 mg, 200 mg and 400 mg strengths. The drug is the generic version of Celebrex capsules of Pfizer.
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced that the U.S. Food and Drug Administration has granted the Company s PLX-PAD cells Orphan Drug Designation in the treatment of severe preeclampsia. Attainment of Orphan Drug Designation for our cells in severe preeclampsia exemplifies o
Aurobindo declared that the Food and Drug Administration approved its famotidine tablets in the 20 mg and 40 mg strengths to treat gastroesophageal reflux diesease and active duodenal ulcer. The permitted ANDA is bioequivalent and therapeutically equivalent to Pepcid tablets, 20 mg and 40 mg, from Valeant Pharmaceuticals. Famotidine tablets have an